These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19883342)

  • 1. Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial.
    Gialamas A; Yelland LN; Ryan P; Willson K; Laurence CO; Bubner TK; Tideman P; Beilby JJ
    Med J Aust; 2009 Nov; 191(9):487-91. PubMed ID: 19883342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial.
    Bubner TK; Laurence CO; Gialamas A; Yelland LN; Ryan P; Willson KJ; Tideman P; Worley P; Beilby JJ
    Med J Aust; 2009 Jun; 190(11):624-6. PubMed ID: 19485840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial.
    Laurence CO; Moss JR; Briggs NE; Beilby JJ;
    BMC Health Serv Res; 2010 Jun; 10():165. PubMed ID: 20546629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics.
    Laurence C; Gialamas A; Yelland L; Bubner T; Ryan P; Willson K; Glastonbury B; Gill J; Shephard M; Beilby J;
    Trials; 2008 Aug; 9():50. PubMed ID: 18681979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care testing for patients with diabetes, hyperlipidaemia or coagulation disorders in the general practice setting: a systematic review.
    Gialamas A; St John A; Laurence CO; Bubner TK;
    Fam Pract; 2010 Feb; 27(1):17-24. PubMed ID: 19969524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
    Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V
    PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence.
    Lyons I; Barber N; Raynor DK; Wei L
    BMJ Qual Saf; 2016 Oct; 25(10):759-69. PubMed ID: 26755665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation.
    Wells S; Rafter N; Kenealy T; Herd G; Eggleton K; Lightfoot R; Arcus K; Wadham A; Jiang Y; Bullen C
    PLoS One; 2017; 12(4):e0174504. PubMed ID: 28422968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient satisfaction with point-of-care testing in general practice.
    Laurence CO; Gialamas A; Bubner T; Yelland L; Willson K; Ryan P; Beilby J;
    Br J Gen Pract; 2010 Mar; 60(572):e98-104. PubMed ID: 20202351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
    Choudhry NK; Isaac T; Lauffenburger JC; Gopalakrishnan C; Lee M; Vachon A; Iliadis TL; Hollands W; Elman S; Kraft JM; Naseem S; Doheny S; Lee J; Barberio J; Patel L; Khan NF; Gagne JJ; Jackevicius CA; Fischer MA; Solomon DH; Sequist TD
    JAMA Intern Med; 2018 Sep; 178(9):1182-1189. PubMed ID: 30083727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a brief action planning intervention on adherence to double-blind study medication, compared to a standard trial protocol, in the Atorvastatin in Factorial with Omega EE90 Risk Reduction in Diabetes (AFORRD) clinical trial: A cluster randomised sub-study.
    Farmer AJ; Oke J; Hardeman W; Tucker L; Sutton S; Kinmonth AL; Griffin S; Holman RR
    Diabetes Res Clin Pract; 2016 Oct; 120():56-64. PubMed ID: 27522034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a self-management intervention with personalised genetic and lifestyle-related risk information on coronary heart disease and diabetes-related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trial.
    Davies AK; McGale N; Humphries SE; Hirani SP; Beaney KE; Bappa DA; McCabe JG; Newman SP
    Trials; 2015 Dec; 16():547. PubMed ID: 26631181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an accreditation program for Point of Care Testing (PoCT) in general practice.
    Tirimacco R; Glastonbury B; Laurence CO; Bubner TK; Shephard MD; Beilby JJ
    Aust Health Rev; 2011 May; 35(2):230-4. PubMed ID: 21612739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial.
    Huang Z; Tan E; Lum E; Sloot P; Boehm BO; Car J
    JMIR Mhealth Uhealth; 2019 Sep; 7(9):e14914. PubMed ID: 31516127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial.
    Furler J; O'Neal D; Speight J; Manski-Nankervis JA; Gorelik A; Holmes-Truscott E; Ginnivan L; Young D; Best J; ; Patterson E; Liew D; Segal L; May C; Blackberry I
    BMJ; 2017 Mar; 356():j783. PubMed ID: 28274941
    [No Abstract]   [Full Text] [Related]  

  • 18. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
    Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case management for depression by health care assistants in small primary care practices: a cluster randomized trial.
    Gensichen J; von Korff M; Peitz M; Muth C; Beyer M; Güthlin C; Torge M; Petersen JJ; Rosemann T; König J; Gerlach FM;
    Ann Intern Med; 2009 Sep; 151(6):369-78. PubMed ID: 19755362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient factors associated with diabetes medication adherence at different health literacy levels: a cross-sectional study at a family medicine clinic.
    Huang YM; Shiyanbola OO; Chan HY; Smith PD
    Postgrad Med; 2020 May; 132(4):328-336. PubMed ID: 32233892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.